--- title: "BPMC.US (BPMC.US) — 相关新闻" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/BPMC.US/news.md" symbol: "BPMC.US" name: "BPMC.US" parent: "https://longbridge.com/zh-CN/quote/BPMC.US.md" datetime: "2026-03-13T04:44:30.747Z" locales: - [en](https://longbridge.com/en/quote/BPMC.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/BPMC.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/BPMC.US/news.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/BPMC.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BPMC.US/news.md) # BPMC.US (BPMC.US) — 相关新闻 ### [Four-year data shows long-term benefit and safety of AYVAKIT in Indolent Systemic Mastocytosis. 12 presentations at AAAAI Meeting.](https://longbridge.com/zh-CN/news/277313719.md) *2026-02-28T14:47:05.000Z* > A recent real-world study on AYVAKIT has shown significant improvements in symptoms related to Indolent Systemic Mastocy ### [09:45 ETBlueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis](https://longbridge.com/zh-CN/news/277312332.md) *2026-02-28T14:45:38.000Z* > Blueprint Medicines, a Sanofi company, announced positive four-year data for AYVAKIT® (avapritinib) in treating indolent ### [BeOne Medicines Earnings Report: Q4 Overview](https://longbridge.com/zh-CN/news/277027138.md) *2026-02-26T11:02:14.000Z* > BeOne Medicines (NASDAQ:ONC) reported its Q4 earnings on February 26, 2026, beating estimates by 37.32% with an EPS of $ ### [Slate Medicines raises $130m in funds to progress anti-PACAP treatments](https://longbridge.com/zh-CN/news/276876652.md) *2026-02-25T11:15:52.000Z* > Slate Medicines has raised $130 million in a Series A financing round to advance its anti-PACAP migraine therapies, spec ### [Blueprint Technologies partnered with Superblocks for faster enterprise app development and AI innovation. (Characters: 97)](https://longbridge.com/zh-CN/news/274679730.md) *2026-02-03T15:05:41.000Z* > Today, in Bellevue, Washington, Blueprint Technologies unveiled a new partnership with Superblocks, an AI platform speci ### [Sanofi prepares for the future and once again raises its sacrosanct dividend](https://longbridge.com/zh-CN/news/274306024.md) *2026-01-30T12:07:52.000Z* > Sanofi, under CEO Paul Hudson, is preparing for the future by reducing its reliance on Dupixent, which accounts for a si ### [Sanofi targets high single digit sales growth in 2026, plans share buyback](https://longbridge.com/zh-CN/news/274100856.md) *2026-01-29T06:30:00.000Z*